We are a company that allows patients to receive personalized treatment for their disease through molecular testing and genetic diagnosis, allowing them to live longer and improve their quality of life.
We ensure fast access to the best treatments by providing premium genomic testing services.
We generate high-quality genomic information and combine it with clinical data from each patient to develop in-depth scientific and bioinformatic analyses with the aim of providing the best therapeutic recommendation for each case.
The support of carried out more than
genomic studies with the highest technology
and scientific quality in Latin America
The information from these studies was supervised by a team of specialists at Biomakers.Our recommendations are not intended to replace the consensus guidelines of medical associations nor current cancer treatment guidelines.
52-gene multigenic panel + PD-L1 + microsatellite instability with all clinically actionable targets